Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

I Khouri

Showing results (21-30 of 74) with videos related to

Pageof 8
Sort By:
Journal of Clinical Apheresis|December 18, 2001
Donor lymphocyte apheresis for adoptive immunotherapy compared with blood stem cell apheresisM Körbling, S Giralt, I Khouri, et al.
Blood|June 1, 1995
Percentage of Philadelphia chromosome (Ph)-negative and Ph-positive cells found after autologous transplantation for chronic myelogenous leukemia depends on percentage of diploid cells induced by conventional-dose chemotherapy before collection of autologous cellsM Talpaz, H Kantarjian, J Liang, et al.
Leukemia & Lymphoma|May 1, 1995
A phase I-II study of high-dose thiotepa, busulfan and cyclophosphamide as a preparative regimen for autologous transplantation for malignant lymphomaD Przepiorka, R Nath, C Ippoliti, et al.
Bone Marrow Transplantation|June 30, 2009
Infections in non-myeloablative hematopoietic stem cell transplantation patients with lymphoid malignancies: spectrum of infections, predictors of outcome and proposed guidelines for fungal infection preventionA Safdar, G H Rodriguez, C N Mihu, et al.
Urology|December 1, 1995
Intravesicular carboprost for the treatment of hemorrhagic cystitis after marrow transplantationC Ippoliti, D Przepiorka, R Mehra, et al.
Bone Marrow Transplantation|July 1, 1994
High doses of cyclophosphamide, etoposide and total body irradiation followed by autologous stem cell transplantation in the management of patients with chronic myelogenous leukemiaH M Kantarjian, M Talpaz, B Andersson, et al.
Bone Marrow Transplantation|April 1, 1995
High-dose chemotherapy with BEAC regimen and autologous bone marrow transplantation for intermediate grade and immunoblastic lymphoma: durable complete remissions, but a high rate of regimen-related toxicityK van Besien, J Tabocoff, M Rodriguez, et al.
Progress in Clinical and Biological Research|January 1, 1992
Molecular approaches to purging of chronic myelogenous leukemia marrow in autologous transplantationT Yuan, Y Q Zhou, C V Herst, et al.
Cytokines and Molecular Therapy|June 1, 1995
Interferon-alpha and interleukin-2 as treatment for leukemia relapse after allogeneic bone marrow transplantationS Giralt, S O'Brien, M Talpaz, et al.
Bone Marrow Transplantation|March 19, 2008
Rituximab for passenger lymphocyte syndrome associated with allogeneic SCTH J Lee, A Gulbis, L De Padua Silva, et al.
Pageof 8

Showing results (21-30 of 74) with videos related to

Sort By:
Pageof 8
Journal of Clinical Apheresis|December 18, 2001
Donor lymphocyte apheresis for adoptive immunotherapy compared with blood stem cell apheresisM Körbling, S Giralt, I Khouri, et al.
Blood|June 1, 1995
Percentage of Philadelphia chromosome (Ph)-negative and Ph-positive cells found after autologous transplantation for chronic myelogenous leukemia depends on percentage of diploid cells induced by conventional-dose chemotherapy before collection of autologous cellsM Talpaz, H Kantarjian, J Liang, et al.
Leukemia & Lymphoma|May 1, 1995
A phase I-II study of high-dose thiotepa, busulfan and cyclophosphamide as a preparative regimen for autologous transplantation for malignant lymphomaD Przepiorka, R Nath, C Ippoliti, et al.
Bone Marrow Transplantation|June 30, 2009
Infections in non-myeloablative hematopoietic stem cell transplantation patients with lymphoid malignancies: spectrum of infections, predictors of outcome and proposed guidelines for fungal infection preventionA Safdar, G H Rodriguez, C N Mihu, et al.
Urology|December 1, 1995
Intravesicular carboprost for the treatment of hemorrhagic cystitis after marrow transplantationC Ippoliti, D Przepiorka, R Mehra, et al.
Bone Marrow Transplantation|July 1, 1994
High doses of cyclophosphamide, etoposide and total body irradiation followed by autologous stem cell transplantation in the management of patients with chronic myelogenous leukemiaH M Kantarjian, M Talpaz, B Andersson, et al.
Bone Marrow Transplantation|April 1, 1995
High-dose chemotherapy with BEAC regimen and autologous bone marrow transplantation for intermediate grade and immunoblastic lymphoma: durable complete remissions, but a high rate of regimen-related toxicityK van Besien, J Tabocoff, M Rodriguez, et al.
Progress in Clinical and Biological Research|January 1, 1992
Molecular approaches to purging of chronic myelogenous leukemia marrow in autologous transplantationT Yuan, Y Q Zhou, C V Herst, et al.
Cytokines and Molecular Therapy|June 1, 1995
Interferon-alpha and interleukin-2 as treatment for leukemia relapse after allogeneic bone marrow transplantationS Giralt, S O'Brien, M Talpaz, et al.
Bone Marrow Transplantation|March 19, 2008
Rituximab for passenger lymphocyte syndrome associated with allogeneic SCTH J Lee, A Gulbis, L De Padua Silva, et al.
Pageof 8